Dobutamine-induced ST-segment elevation in patients with acute myocardial infarction and the role of myocardial ischemia, viability, and ventricular dyssynergy

American Journal of Cardiology

Volumn 79, Issue 6, 1997, Pages 733-737

  Ricci, Roberto ^a,b,c   Bigi, Riccardo ^a,b,c   Galati, Alfonso ^a,b,c   Bandini, Paolo ^a,b,c   Coletta, Claudio ^a,b,c   Fiorentini, Cesare ^a,b,c   Lumia, Francesca ^a,b,c   Occhi, Giuseppe ^a,b,c   Ceci, Vincenzo ^a,b,c  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b Azienda Ospedaliera E Morelli   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CREATINE KINASE; DOBUTAMINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART INFARCTION LOCALIZATION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE CONTRACTION; HEART VENTRICLE WALL MOTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; Q WAVE; ST SEGMENT ELEVATION;

ADULT; AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; DOBUTAMINE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; OBSERVER VARIATION; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION;

EID: 0030901343     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00859-4     Document Type: Article

References (29)

1. Bruce RA, Gey GO Jr, Cooper MN, Fisher LD, Peterson DR. Seattle Heart Watch: initial clinical, circulatory and electrocardiographic response to maximal exercise. Am J Cardiol. 33:1974;459-470.
2. De Feyter PJ, Majid PA, Van Eenige MJ, Wardeh R, Wempe FN, Roos JP. Clinical significance of exercise-induced ST-segment elevation. Correlative angiographic study in patients with ischaemic heart disease. Br Heart J. 46:1981;84-92.
3. Bruce RA, Fisher LD, Pettinger M, Weiner DA, Chaitman BR. ST-segment elevation with exercise: a marker of poor ventricular function and prognosis. Coronary Artery Surgery Study (CASS) confirmation of Seattle Heart Watch results. Circulation. 77:1988;897-905.
4. Chahine RA, Raizner AE, Ishimori T. The clinical significance of exercise-induced ST-segment elevation. Circulation. 54:1976;209-213.
5. Waters DD, Chaitman BR, Bourassa MG, Tubau JF. Clinical and angiographic correlates of exercise-induced ST-segment elevation. Increased detection with multiple ECG leads. Circulation. 61:1980;286-296.
6. Dunn RF, Bailey IK, Uren R, Kelly DT. Exercise-induced ST-segment elevation correlation of thallium 201 myocardial perfusion scanning and coronary arteriography. Circulation. 61:1980;989-995.
7. Lahiri A, Balasubramanian V, Millar-Craig MW, Crawley J, Raftery EB. Exercise-induced ST-segment elevation: electrocardiographic, angiographic and scintigraphic evaluation. Br Heart J. 43:1980;582-588.
8. Sriwattanakomen S, Ticzon AR, Zubritzky SA, Blobner CG, Rice M, Duffy FC, Lanna EF. ST-segment elevation during exercise: electrocardiographic and arteriographic correlation in 38 patients. Am J Cardiol. 45:1980;762-768.
9. Gerwitz H, Sullivan M, O'Reilly G, Winter S, Most AS. Role of myocardial ischemia in the genesis of exercise-induced ST-segment elevation in previous anterior myocardial infarction. Am J Cardiol. 51:1983;1293-1305.
10. Auora R, Ioachim L, Matza D, Horowitz SF. The role of ischemia and ventricular asynergy in the genesis of exercise-induced ST elevation. Clin Cardiol. 11:1988;127-139.
11. Nosratian FJ, Froelicher VF. ST elevation during exercise testing. Am J Cardiol. 63:1989;986-988.
12. Cahine RA, Lowery MH, Bauerlein J. Interpretation of the exercise-induced ST-segment elevation. Am J Cardiol. 72:1993;100-102.
13. Coma-Canella I, de Val Gomez M, Terol I, Rodrigo F, Castro JM. Radionuclide studies in patients with stress-induced ST-segment elevation after acute myocardial infarction. Am Heart J. 128:1994;459-465.
14. Margonato A, Ballarotto C, Bonetti F, Cappelletti A, Sciammarella M, Cinaflone D, Chierchia SL. Assessment of residual tissue viability by exercise testing in recent myocardial infarction: comparison of the electrocardiogram and myocardial perfusion scintigraphy. J Am Coll Cardiol. 19:1992;948-952.
15. Margonato A, Chierchia SL, Xuereb RG, Xuereb M, Fragasso G, Cappelletti A, Landoni C, Lucignani G, Fazio F. Specificity and sensitivity of exercise-induced ST-segment elevation for detection of residual viability: comparison with fluorodeoxyglucose and positron emission tomography. J Am Coll Cardiol. 25:1995;1032-1038.
16. Berthe C, Pierard LA, Hiernaux M, Trotteur G, Lempereur P, Carlier J, Kulbertus HE. Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol. 58:1986;1167-1172.
17. Smart SC, Sawada S, Ryan T, Segar D, Htherton L, Berkovitz K, Bourdillon PD, Feigenbaum H. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation. 88:1993;405-415.
18. Previtali M, Poli A, Lanzarini L, Fetiveau R, Mussini A, Ferrario M. Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol. 72:1993;124G-130G.
19. McNeill AJ, Fioretti PM, El-Said EM, Salustri A, Forster T, Roeland JRTC. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol. 70:1992;41-46.
20. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echo. 2:1989;358-367.
21. Arnese M, Fioretti PM, Cornel JM, Postma-Tjoa J, Reijs AE, Roelandt JRTC. Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography: a marker of myocardial ischemia or a mechanical phenomenon? Am J Cardiol. 73:1994;896-899.
22. Marcovitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol. 69:1992;1269-1273.
23. Armstrong WF, O'Donnell J, Ryan T, Feigenbaum H. Effect of prior myocardial infarction and extent and location of coronary artery disease on accuracy of exercise echocardiography. J Am Coll Cardiol. 10:1987;531-538.
24. Fox KM, Jonathan A, Selwyn A. Significance of exercise-induced ST-segment elevation in patients with previous myocardial infarction. Br Heart J. 49:1983;15-19.
25. Lombardo A, Loperfido F, Pennestrì F, Rossi E, Patrizi R, Cristinziani G, Catapano G, Maseri A. Significance of transient ST-T segment changes during dobutamine testing in Q-wave myocardial infarction. J Am Coll Cardiol. 27:1996;599-605.
26. Gould KL. Myocardial viability. What does it mean and how do we measure it? Circulation. 83:1991;333-335.
27. Gropler RJ, Siegel BA, Lee KJ, Moerlein SM, Perry DJ, Bergmann SR, Geltman EM. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med. 31:1990;1749-1756.
28. Tamaki N, Yonekura Y, Konishi J. Myocardial FDG PET studies with the fasting, oral glucose loading or insulin clamp method. J Nucl Med. 33:1992;1263-1268.
29. Elhendy A, Geleijnse ML, Roelandt JRTC, van Domburg RT, Cornel JH, TenCate FJ, Postma-Tjoa J, Reijs AEM, El-Said GM, Fioretti PM. Evaluation by quantitative 99m-technetium MIBI SPECT and echocardiography of myocardial perfusion and wall motion abnormalities in patients with dobutamine-induced ST-segment elevation. Am J Cardiol. 76:1995;441-448.